Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Amyloid related imaging abnormality-oedema/effusion: Which Medications Cause It? (680 Reports Across 8 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Amyloid related imaging abnormality-oedema/effusion has been reported as an adverse event with 8 different drugs in the FDA's FAERS database, with 680 total reports. 16 of these reports resulted in death.The drugs most commonly associated with Amyloid related imaging abnormality-oedema/effusion are LECANEMAB-IRMB, DONANEMAB-AZBT, and ADUCANUMAB-AVWA.

680
Total Reports
8
Drugs Involved
16
Deaths
148
Hospitalizations
73.4 yrs
Average Patient Age
66.9% / 33.1%
Female / Male

Which Drugs Cause Amyloid related imaging abnormality-oedema/effusion Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
LECANEMAB-IRMB 307 12.4% 4 80 6
DONANEMAB-AZBT 185 18.2% 2 20 2
ADUCANUMAB-AVWA 90 21.9% 4 8 0
ADUCANUMAB 53 44.9% 1 10 1
LECANEMAB 39 22.8% 5 25 7
FLORBETAPIR F-18 28 28.3% 0 2 0
FLORQUINITAU 19 59.4% 0 1 0
FLORBETABEN F-18 6 37.5% 0 0 0

View all 8 drugs →

Top 3 Drugs Associated With Amyloid related imaging abnormality-oedema/effusion

307 reports
185 reports
90 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)